VSee Health Statistics
Total Valuation
VSee Health has a market cap or net worth of $17.36 million. The enterprise value is $29.78 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VSee Health has 17.02 million shares outstanding. The number of shares has increased by 56.55% in one year.
| Current Share Class | 17.02M |
| Shares Outstanding | 17.02M |
| Shares Change (YoY) | +56.55% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 41.27% |
| Owned by Institutions (%) | 8.00% |
| Float | 7.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| Forward PS | 4.03 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.86 |
Financial Efficiency
Return on equity (ROE) is -259.62% and return on invested capital (ROIC) is -13.39%.
| Return on Equity (ROE) | -259.62% |
| Return on Assets (ROA) | -10.54% |
| Return on Invested Capital (ROIC) | -13.39% |
| Return on Capital Employed (ROCE) | 169.03% |
| Revenue Per Employee | $89,613 |
| Profits Per Employee | -$413,658 |
| Employee Count | 154 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VSee Health has paid $53,476 in taxes.
| Income Tax | 53,476 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.08% in the last 52 weeks. The beta is 0.47, so VSee Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -28.08% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 58.42 |
| Average Volume (20 Days) | 41,209,992 |
Short Selling Information
The latest short interest is 9,166, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 9,166 |
| Short Previous Month | 70,268 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
In the last 12 months, VSee Health had revenue of $13.80 million and -$63.70 million in losses. Loss per share was -$4.00.
| Revenue | 13.80M |
| Gross Profit | 8.61M |
| Operating Income | -8.20M |
| Pretax Income | -63.65M |
| Net Income | -63.70M |
| EBITDA | -5.58M |
| EBIT | -8.20M |
| Loss Per Share | -$4.00 |
Full Income Statement Balance Sheet
The company has $291,595 in cash and $12.71 million in debt, giving a net cash position of -$12.42 million or -$0.73 per share.
| Cash & Cash Equivalents | 291,595 |
| Total Debt | 12.71M |
| Net Cash | -12.42M |
| Net Cash Per Share | -$0.73 |
| Equity (Book Value) | -5.74M |
| Book Value Per Share | -0.35 |
| Working Capital | -20.50M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$3.96 million and capital expenditures -$25,220, giving a free cash flow of -$3.99 million.
| Operating Cash Flow | -3.96M |
| Capital Expenditures | -25,220 |
| Free Cash Flow | -3.99M |
| FCF Per Share | -$0.23 |
Full Cash Flow Statement Margins
| Gross Margin | 62.42% |
| Operating Margin | -59.38% |
| Pretax Margin | -461.22% |
| Profit Margin | n/a |
| EBITDA Margin | -40.43% |
| EBIT Margin | -59.38% |
| FCF Margin | n/a |
Dividends & Yields
VSee Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -56.55% |
| Shareholder Yield | -56.55% |
| Earnings Yield | -366.89% |
| FCF Yield | -22.95% |
Analyst Forecast
The average price target for VSee Health is $5.00, which is 390.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 390.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VSee Health has an Altman Z-Score of -7.09 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.09 |
| Piotroski F-Score | 1 |